Conference item
Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
- Abstract:
- Can effective treatment of psoriasis (PsO) prevent the development of psoriatic arthritis (PsA)? In a Hot Topic Debate at the 7th World Psoriasis & Psoriatic Arthritis Conference, Dr. Soriano and Dr. Ogdie, both experts in the field, presented contrasting views based on existing research and clinical studies.1 Dr. Soriano argued that biologic treatments for PsO may reduce PsA risk, citing several retrospective studies. On the other hand, Dr. Ogdie argued that current observational data are plagued by biases, making it difficult to conclude whether biologics play a protective role. The session outlined the complexity of this issue, with both speakers agreeing on the need for prospective randomised controlled trials, such as the ongoing PAMPA study, to provide definitive answers. Prof. Laura Coates added that identifying at-risk patients and intervening early to potentially prevent PsA may point to a strategic research approach to address these unanswered questions.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 359.7KB, Terms of use)
-
- Publisher copy:
- 10.55788/4f7dfc9b
Authors
- Publisher:
- Medicom Medical Publishers
- Host title:
- Proceedings of the 7th IFPA WPPAC
- Pages:
- 10-14
- Publication date:
- 2024-11-11
- Event title:
- 7th World Psoriasis & Psoriatic Arthritis Conference (IFPA-WPPAC 2024)
- Event location:
- Stockholm, Sweden
- Event website:
- https://conference.ifpa-pso.com/
- Event start date:
- 2024-06-27
- Event end date:
- 2024-06-29
- DOI:
- ISSN:
-
2950-4465
- Language:
-
English
- Keywords:
- Pubs id:
-
2068846
- Local pid:
-
pubs:2068846
- Deposit date:
-
2025-03-10
Terms of use
- Copyright holder:
- Vivekanantham et al.
- Copyright date:
- 2024
- Rights statement:
- © 2024 the author(s). Published with license by Medicom Medical Publishers. This is an Open Access article distributed under the terms of the CC BY-NC 4.0 license, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Notes:
- This paper was presented at the 7th World Psoriasis & Psoriatic Arthritis Conference (IFPA-WPPAC 2024), 27th-29th June 2024, Stockholm, Sweden.
If you are the owner of this record, you can report an update to it here: Report update to this record